Bioceres posts Q3 2026 net loss as revenues fall 23%

Bioceres Crop Solutions posted a net loss of $10 million in its fiscal third quarter ended March 31, 2026, as total revenues from continuing operations fell 23% year-on-year to $39.4 million, the company reported on May 11.

Gross profit declined 30% to $12.7 million, with a gross margin of 32%, reflecting lower revenues and a non-recurring inoculant inventory obsolescence charge related to normalization efforts during the period. Adjusted EBITDA was negative $0.6 million, essentially breakeven. SG&A expenses fell 16% year-on-year as the Rosario, Argentina-based company continued a cost-reduction program.

Crop Protection revenues of $24.6 million slid 18% on softer demand for adjuvants, ongoing channel inventory adjustments and competitive pressure in certain product categories. Seeds revenues also declined as Bioceres transitions toward an asset-light model, reducing working capital intensity. The one bright spot was Crop Nutrition, which grew 15%, driven by microbeaded fertilizer products.

Bioceres’ Pro Farm Group — which was foreclosed and auctioned in January 2026 — has been classified as discontinued operations and is excluded from these results. The company said it is pursuing refinancing, asset disposal and a three-year plan to restore profitability, while legal remedies related to the Pro Farm foreclosure continue.

The 15% growth in Crop Nutrition is the clearest signal of where Bioceres sees structural demand. Microbeaded fertilizers — which improve nutrient placement and uptake efficiency — are gaining traction among growers managing tighter input budgets. Stabilizing that segment while Crop Protection works through channel inventory will be the key test for the next two quarters.